期刊文献+

极低出生体质量早产儿视网膜病变筛查及相关因素分析 被引量:12

Retinopathy of prematurity screening among very low birth weight infants and related factors analysis
暂未订购
导出
摘要 目的分析极低出生体质量儿中早产儿视网膜病变(retinopathyofprematurity,ROP)发病情况及相关的危险因素。方法选择2009年3月至2010年12月我院住院的出生体质量≤1500g的早产儿,使用RetCam数字视网膜照相机和间接检眼镜进行ROP筛查,分析相关因素。结果筛查出生体质量≤1500g患儿519例(1038眼),发现ROP313眼(30.15%),激光治疗81眼(7.80%)。出生体质量≤1000g组、〉1000~1500g组ROP检出率(52.78%、28.47%)、激光治疗百分比(19.44%、6.94%)差异均有统计学意义(均为P〈0.05);出生体质量≤1000g的38眼中I区ROP发生率(52.63%)、附加病变发生率(36.84%)明显高于出生体质量〉1000g者(均为P〈0.05);出生胎龄≤28周、〉28~32周、〉32~35周ROP检出率(46.07%、31.07%、7.24%)、激光治疗的百分比(17.98%、6.78%、0.66%)间差异均有统计学意义(均为P〈0.05);有吸氧史者ROP发生率(44.17%)和激光治疗比率(11.04%)明显高于无吸氧史者(6.48%、2.33%)(P〈0.05),多胎与单胎间发生ROP的差异无统计学意义(24.51%、31.53%)(χ2=3.841,P=0.050)。结论出生胎龄越小,出生体质量越低,ROP检出率越高,病变越重。吸氧是ROP发生的高危因素。应规范筛查ROP,及时治疗。 Objective To observe the prevalence and the risk factors of retinop- athy of prematurity (ROP)among very low birth weight infants. Methods Totall 519 very low birth weight infants ( 1038 eyes)were treated in our hospital from March 2009 to December 2010. ROP were screened by RetCam fundus widefield imaging camera or a binocular indirect ophthalmoscope until the retina was entirely vascularised, and the related factors were analyzed. Results The incidence of ROP and that treated by laser among very low birth weight infants in our study was 30. 15% (313 eyes)and 7.80% (81 eyes). The incidence of ROP (52. 78% vs 28. 57% ) and that treated by laser ( 19.44% vs 7.04% ) in subgroup with birth weight ≤ 1000 g was significantly higher than the subgroup with birth weight from 1001 g to 1500 g ( all P 〈 0.05 ). The Zone 1 ROP(52.53% )and with plus disease (35.84%)among the infants with birth weight 1000 g were more than those among the infants with birth weight 〉 1000 g ( all P 〈 0.05). There were statistical difference in the ROP incidence(46.07% , 31.07% and 7.24% )and that treated by laser( 17.98% , 5.78% and 1.57% ) among group with ges- tional age ~〈 28 weeks, group with gestional age from 28 weeks to 32 weeks and group with gestional age from 32 weeks to 35 weeks) ( all P 〈 0.05 ). The incidence of ROP and that treated by laser in oxygen group(44.17% , ll. 04% )were higher than those in non-oxygen group(5.48% , 2.33% ) ( all P 〈 0.05 ). ROP infants in multiple gestational births group was not significantly different from that in single gestational births group (24.51% , 31.53% ) (χ2 = 3.841, P = 0.050). Conclusion The shorter gestational age and lower birth weight are, the higher incidence and more severe degree of ROP are. Oxygen is the high risk factor of ROP. Routine screening of fundus in premature infants mav be helnful for the earlv detection of ROP.
出处 《眼科新进展》 CAS 北大核心 2014年第4期361-363,共3页 Recent Advances in Ophthalmology
关键词 早产儿 极低出生体质量儿 视网膜病变 危险因素 premature infant very low birth weight infant retinopathy risk fac-tor
  • 相关文献

参考文献15

  • 1An International Committee for the Classification of Retinopathy of Prematurity. The international classifcation of retinopathy of prematurity revisited [J]. Arch Ophthalmol, 2005,123 (7) : 991- 999.
  • 2Good WV, Hardy RA, Dobson V, Palmer EA, Phelps DL, Quintos M ,et al. The incidence and course of retinopathy of prematurity : Findings from the early treatment for retinopathy of prematurity study [J]. Pediatrics ,2005,116 (1) : 15-23.
  • 3Todd DA, Wright A, Smith J. Severe retinopathy of prematurity in infants < 30 weeks' gestation in New South Wales and the Australian Capital Territory from 1992 to 2002 [J]. Arch Dis Child Fetal Neonatal Ed ,2007 ,92( 4) :F251-254.
  • 4Dhaliwal CA,FIeck BW, Wright E,Graham C,McIntosh N. Retinopathy of prematurity in small-for-gestational age infants compared with those of appropriate size for gestational age [J]. Arch Dis Child Fetal Neonatal Ed ,2009 ,94( 3) :FI93-195.
  • 5Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results [J]. Arch Ophthalmol, 1988, 106 (4) : 471- 479.
  • 6Rekhat S, Battu RR. Retinopathy of prematurity: Incidence and risk factors[J]. Indian Pediatr,1996,33(!2) :999-1003.
  • 7Tasman W, Patz A, Mcnamara JA, Kaiser RS, Trese MT, Smith BT. Retinopathy of prematurity: The life of a lifetime disease [J]. Am J Ophthalmol,2006, 141 (1) : 167-174.
  • 8Gotz- WieckowskaA, Kociecki J, Burchardt- Kroll E, Gadzinowski J. The results of diode treatment of active phase of retinopathy of prematurity [J]. Klin Oczna ,2003,105 (5) :395-397.
  • 9Foroozan R, Connolly BP, Tasnan WS. Outcomes after laser therapy for threshold retinopathy of prematurity [J]. Ophthalmology,2001 ,108(9) : 1644-1646.
  • 10Rao R,Jonsson NJ,Ventura C,Gelman R,Lindquist MA,Casper DS ,et al. Plus disease in retinopathy of prematurity: diagnostic impact of field of view [J]. Retina ,2012 ,32( 6) : 1148-1155.

二级参考文献38

共引文献143

同被引文献128

  • 1Rovers MM,Schilder AG,Zielhuis GA,Rosenfeld RM,张江平,杨妙丽,张全安.中耳炎[J].国外医学(耳鼻咽喉科学分册),2005,29(3):141-143. 被引量:442
  • 2Madhulika K,Ganga G, Jack P, et al. Diagnosing significant PDA using natriuretie peptides in preterm neonates: a systematic review [ J ]. Pediatrics,2015,135 (2) :e510 - e525.
  • 3Ocehipinti F,de Carolis MP, de Rosa G, et al. Correlafion analysis be- tween eehocardiographic flow pattern and N-terminal-pro-brain natriure- tie peptide for early targeted treatment of patent duetus arteriosus [ J ]. J Matern Fetal Neonatal Med,2014,27 ( 17 ) : 1800 - 1804.
  • 4Mine K, Ohashi A,Tsuji S, et al. B-type natriuretic peptide for assess- ment of haemodynamieally significant patent ductus arteriosus in prema- ture infants [ J ]. Acta Paediatfiea,2013,102 ( 8 ) : e347 - e352.
  • 5Cea LB. Nalriuretie peptide family: new aspects [ J ]. Curr Med Chem Cardiovasc Hematol Agents,2005,3 ( 2 ) : 87 - 98.
  • 6Ojji DB, Opie LH, Lecour S, et al. The proposed role of plasma NT pro- brain natriuretic peptide in assessing cardiac remodelling in hyperten- sive African subjects [ J ]. Cardiovasc J Afr,2014,25 ( 5 ) : 233 - 238.
  • 7Chfistenson ES, Collinson PO, deFilippi CR, et al. Heart failure biomar- kers at point-of-care:current utilization and fiature potential[ J ]. Expert Rev Mol Diagn,2014,14(2) :185 -197.
  • 8de Vecchis R,Esposito C,Ariano C,et al. Possible role of BNP for an early diagnosis of asymptomatie left ventricalar dysfunction : a retrospec- tive study [ J ]. Minerva Cardioangio1,2014,62 ( 2 ) : 147 - 159.
  • 9Czernik C, Metze B, Mtiller C, et al. Urinary NT-proBNP and ductal clo- sure in preterm infants[ J ]. J Perinato1,2013,33 ( 3 ) : 212 - 217.
  • 10Moriichi A, Cho K, Mizushima M, et aL B-type natriuretic peptide levels at birth predict cardiac dyshnction in neonates[ J]. Pediatr lnt,2012, 54(1 ) :89 -93.

引证文献12

二级引证文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部